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Nephrocalcinosis: A Diagnostic Conundrum
Lalathaksha Kumbar and Jerry Yee
Clinical Presentation
A 26-year-old muscular man was referred for evaluation
of elevated serum creatinine concentration of 4 mg/dL
without attributable symptoms. The patient reported
taking creatine supplements and ibuprofen, 800 mg,
before exercise. He also regularly consumed protein
shakes. Two years prior, during a physical examination
required for athletic participation, an elevated serum
creatinine concentration (1.87 mg/dL; from a baseline
of 1.4 mg/dL) with proteinuria (2+) but no hematuria
was noted. An ultrasound showed preserved kidney size
with increased medullary echogenicity, suggesting
medullary nephrocalcinosis. Kidney biopsy showed
focal segmental glomerulosclerosis, severe interstitial
fibrosis, and mild arteriosclerosis.
The patient’s family history lacked any record of
kidney disease. He had no known allergies and denied
toxic alcohol ingestion or use of tobacco, anabolic
steroids, or prescription medications. On examination,
the patient was obese (body mass index, 32 kg/m2)
and hypertensive (blood pressure, 146/93 mm Hg).
Urinalysis showed proteinuria with protein excretion >
300 mg/dL, and by microscopy, there were 2 to 3 red
blood cells and 6 to 10 white blood cells per highpower field, with an occasional granular cast. Laboratory data are presented in Table 1. Chest radiograph
showed the usual cardiomediastinal silhouette and
pulmonary vasculature. Repeat ultrasound showed
shrunken kidneys with echogenic cortices and hyperechoic pyramids consistent with medullary nephrocalcinosis (Fig 1), but findings from computed
tomography (CT) were unremarkable.
• What are the diagnostic challenges in a patient

with chronic kidney disease and
nephrocalcinosis?
• What is the pathophysiologic explanation of

calcium deposition in kidney?
• What is the most likely cause of nephrocalci-
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nosis in this patient?

Discussion
What are the diagnostic challenges in a patient
with chronic kidney disease and
nephrocalcinosis?
Nephrocalcinosis is defined as generalized deposition
of calcium phosphate and/or calcium oxalate in
the kidney, predominantly in the interstitium.1 Calcifications in renal pyramids, characteristic of medullary
xii

nephrocalcinosis, are seen in 98% of nephrocalcinosis
cases.1 Clinical presentation and course are not dependent
on the severity of nephrocalcinosis. The critical feature
noted in nephrocalcinosis is hypercalciuria with or
without hypercalcemia. The presence or absence of
hypercalcemia aids in the evaluation of newly diagnosed
nephrocalcinosis. Conditions with hypercalcemia and
hypercalciuria are systemic disorders, such as primary
hyperparathyroidism, sarcoidosis, hypervitaminosis D,
and milk-alkali syndrome. Hypercalciuria without
hypercalcemia is associated with dysregulation of renal
handling of calcium from a variety of conditions,
including distal tubular acidosis, medullary sponge
kidney, and inherited tubulopathies such as Dent disease.
Our unusual case of a young man with nephrocalcinosis with advanced chronic kidney disease (CKD)
presented with a unique set of challenges in identifying
the underlying cause. The elevated serum creatinine
concentration was unexplained, and he had mild
hypercalcemia without hypercalciuria. Nephrocalcinosis
was identified on renal ultrasound on 2 different
occasions during a 2-year period, but kidney biopsy and
CT of the abdomen failed to show calcifications.
The overall frequency of nephrocalcinosis in a native
kidney biopsy is very low (0.4%).2 An autopsy study
identified 2 distinct histopathologic patterns of nephrocalcinosis by light microscopy. The group with hypercalcemia or hypercalciuria due to malignant tumors,
hyperparathyroidism, sarcoidosis, Dent disease, or
parcelin 1 mutations had finely granular or clumpy
calcium deposits. The group with hyperphosphaturia
(as seen with phosphate-based bowel preparation,
nephrotic syndrome in children, and inherited disorders of renal phosphate wasting) had shell-like or
globular deposits, likely with a phosphate-rich core
surrounded by a thin layer of calcium phosphate. In
both groups, calcifications were seen in both the
cortical and medullary regions.
Our patient had hypovitaminosis D with hypercalcemia without hypercalciuria or hyperphosphaturia. In
an average adult, a 24-hour urine sample is expected to
contain 100 to 250 mg of calcium, which varies with
dietary sodium intake. Hypercalciuria is a prominent
feature in nephrocalcinosis and diseases such as Dent
disease until worsening kidney function limits calcium
excretion. Pre-existing CKD in our patient, with an
estimated glomerular filtration rate of 44 mL/min/
1.73 m2 by the CKD-EPI (CKD Epidemiology Collaboration) creatinine–cystatin C equation, likely explained
the low urinary calcium excretion. Ultrasonographic
examination of kidneys, with its inherent advantages of
the lack of radiation, ease of use, and wide availability,
is the preferred initial test. Magnetic resonance imaging
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Table 1. Laboratory Findings
Values
Parameter
Serum
Creatinine, mg/dL
Calcium, mg/dL
Albumin, g/dL
Vitamin D, ng/mL
ANA
iPTH, pg/mL
Urine
Total protein-creatinine ratio, mg/dL
Albumin-creatinine ratio, mg/dL
RBP-creatinine ratio, μg/g
A1M-creatinine ratio, mg/g
β2-Microglobulin, mg/L
24-h urine calcium, mg
24-h urine phosphorus, g
OCRL1 and CLCN5 mutation screen

Prior Initial Repeat
1.87 3.58 3.7
9.8 9.4 9.7
3.2 3.7 3.6
22
29
ND
76
4.3
1.5
827
21
2.37
38
57
1.1
ND

Abbreviations: A1M, α1-microglobulin; ANA, antinuclear antibody; iPTH, intact
parathyroid hormone; ND, not detected; RBP, retinol-binding protein.

is not sensitive for identification of calcification. In a
limited study, ultrasonography alone had sensitivity of
85% to 90%, whereas CT had sensitivity between 81%
and 86%. Combined ultrasonography with CT had
higher sensitivity (92%) and specificity of 89%, but
there was lower concordance between CT and ultrasonography, making the radiologic diagnosis of nephrocalcinosis a challenge.3
What is the pathophysiologic explanation of
calcium deposition in the kidney?
The exact pathogenesis of calcium deposition in nephrocalcinosis remains unclear. Every day, nearly 99% of
w10 g of diffusible calcium gets reabsorbed in the kidneys.4 The proximal tubule reabsorbs w65% of the filtered

load, with the thick ascending limb of Henle accounting
for 20% to 25%.5 Distal tubule reabsorption of calcium
accounts for 8% to 10%. In this segment, calcium
reabsorption is against a transtubular electrochemical
gradient. Any precipitation of calcium is intricately related
to phosphorus and/or oxalate transport. Calcium precipitation noted in the interstitium could be a de novo
phenomenon or a transtubular migration of intratubular
calcium precipitate. A complex dysregulation between
calcification inhibitors and promoters might play a pivotal
role in interstitial precipitation.6
What is the most likely cause of
nephrocalcinosis in this patient?
Inherited tubulopathies and renal tubular acidosis are
essential conditions leading to nephrocalcinosis. In our
patient, renal tubular acidosis was less likely given the
negative aminoaciduria screen with acidic urine pH.
Elevated retinol-binding protein, β2-microglobulin, and
α1-microglobulin concentrations confirmed lowmolecular-weight proteinuria, suggesting proximal
tubulopathy. The patient’s clinical presentation and lack
of specific metabolic abnormalities excluded Bartter and
Gitelman syndromes.
Dent disease is a familial X-linked recessive disorder
of the proximal tubules that features nephrocalcinosis,
hypercalciuria, low-molecular-weight proteinuria, kidney failure, and metabolic bone disease.7 Dent disease
has no known high-risk populations, but has a marked
male dominance. Although 25% of Dent disease cases
constitute a heterogeneous genetic group with classic
phenotype but lacking known mutations,8,9 threequarters of Dent disease cases are of 1 of 2 types.
Dent type 1, found in 60%, has mutations in Xp11.22
leading to inactivation of the voltage-gated chloride
transporter, CLC5, which is expressed in the kidney.10
This product of the CLCN5 gene is a chloride/proton
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Figure 1. Ultrasound image of the right
kidney with medullary hyperechogenicity
indicating medullary nephrocalcinosis.
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exchanger that facilitates acidification of endosomes in
proximal tubular cells. When CLC5 is inactivated by
mutation (>85 different mutations have been identified9), the disrupted endosomal acidification causes a
failure to process adsorbed low-molecular-weight proteins, leading to proteinuria.11 Dent type 2 is characterized by OCRL1 gene mutations (mutations in this
gene are also seen in the oculocerebrorenal syndrome of
Lowe9,12) and accounts for another 15%. The phosphatase encoded by the OCRL1 gene has overlapping
function with the CLC5 protein in endosomal trafficking, which explains the similar phenotype as Dent
disease type 1.8 In Dent disease, hypercalciuria appears
to be due to hyperabsorption of calcium from the
gastrointestinal tract. The hyperphosphaturia and
greater 1α-hydroxylation seen in Dent disease and
related conditions may be partially because parathyroid
hormone, being a low-molecular-weight protein, has
impaired proximal tubular reabsorption, which in turn
leads to increased activation of parathyroid hormone
receptors in the late proximal tubule.
Evaluation for Dent disease is a must in any male
patient with low-molecular-weight proteinuria, hypercalciuria, and at least 1 of the following: nephrocalcinosis, nephrolithiasis, hematuria, hypophosphatemia,
and CKD. The characteristic triad of low-molecularweight proteinuria, hypercalciuria, and nephrocalcinosis can identify >85% of CLCN5 mutations.9
Hypercalciuria may be absent if decreased glomerular
filtration rate is found. A positive family history and
mutations in CLCN5 or OCRL1 confirm the diagnosis,
but the negative genetic test result is not exclusionary.
Focal global glomerulosclerosis, which is noted in 85%
of Dent disease, is the predominant histopathologic
finding, followed by effacement of foot processes.13
Atypical presentations as seen in our patient have been
reported with focal global glomerulosclerosis.14 Making
an accurate diagnosis of Dent disease is important to help
avoid potentially toxic immunosuppressive medications.
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Final Diagnosis
The constellation of ﬁndings of focal global
glomerulosclerosis with nephrocalcinosis, low-molecularweight proteinuria, and CKD suggested the possibility of
Dent disease. Gene sequencing of OCRL1 and CLCN5
did not detect pathogenic variants. The characteristic
phenotype with the apparent absence of mutations in
known genes conﬁrmed the diagnosis of non-CLCN5
non-OCRL1 Dent disease.
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